false

  • News and events false false
  • 2025 false false
  • 2025 false false
  • July false false
  • MedLase Wins Genesis Accelerator Pitch Competition true true

/content/dam/corporate/images/business-school/news-and-events/2025/medlase_genesis_finale-s-169.jpg

50%

MedLase wins Genesis Accelerator Pitch Competition – A triumph for innovation with impact

2 July 2025

m-hero--style-center-wide

2000.1333.2x.jpeg 4000w, 1280.1280.jpeg 1280w, 440.293.2x.jpeg 880w, 1440.960.2x.jpeg 2880w, 800.533.2x.jpeg 1600w, 220.147.2x.jpeg 440w

false

We’re proud to share that MedLase, a startup incubated within the Genesis Accelerator, has won the Genesis Pitch Competition, securing $30,000 in equity-free funding to advance their groundbreaking work.

Genesis, based in the Discipline of Strategy, Innovation and Entrepreneurship (SIE) at the Business School, plays a critical role in supporting student, staff and alumni-led ventures that bridge research, innovation and impact. MedLase, developed by a team from the School of Biomedical Engineering under the leadership of Professor Gregg Suaning, exemplifies this mission.

The MedLase team - Orsolya Kekesi, Matthew Kolibac, Maximilian Pentecost, and Seb Parsons - is tackling a major healthcare challenge: long wait times for life-changing medical implants. Their innovation streamlines the complex manufacturing of medical devices, significantly reducing production costs and accelerating access for patients in urgent need.

"Winning Genesis validates our idea and all the work we’ve done to develop our proof of concept,” said the MedLase team. “A group of experts have confirmed that it’s not just technically sound, but commercially and socially meaningful. That gives us the confidence to go all in.

Winning Genesis validates our idea and all the work we’ve done to develop our proof of concep. A group of experts have confirmed that it’s not just technically sound, but commercially and socially meaningful. That gives us the confidence to go all in.

The MedLase team

By rethinking how these devices are made - without relying on manual, labour-intensive processes - MedLase is paving the way for scalable, automated solutions that could eventually help hundreds of thousands of people in need of life-changing bionic devices to overcome disease, pain and paralysis worldwide.

This achievement highlights the value of Genesis as part of SIE and the broader University, fostering powerful interdisciplinary collaboration and enabling researchers and entrepreneurs to deliver innovations with real-world impact.

Congratulations to the MedLase team and to the Genesis Accelerator for continuing to shape the future of innovation at Sydney.

Applications are currently open for the next cohort of Genesis, which will run from September to November.

For more information:

Please contact Anna Fitzgerald and Matt Bright, Co-Heads of Genesis Accelerator.

_self

Genesis

h2

Accelerate your startup's growth

cmp-call-to-action--ochre